{"id":27348,"date":"2012-03-19T15:57:25","date_gmt":"2012-03-19T19:57:25","guid":{"rendered":"http:\/\/blogs.nejm.org\/cardioexchange\/?post_type=news&#038;p=27348"},"modified":"2012-03-19T15:57:25","modified_gmt":"2012-03-19T19:57:25","slug":"merck-drops-development-of-oral-vernakalant-for-atrial-fibrillation","status":"publish","type":"post","link":"https:\/\/blogs.nejm.org\/cardioexchange\/2012\/03\/19\/merck-drops-development-of-oral-vernakalant-for-atrial-fibrillation\/","title":{"rendered":"Merck Drops Development of Oral Vernakalant for Atrial Fibrillation"},"content":{"rendered":"<p>Merck has discontinued its development of oral vernakalant for the long-term prevention of atrial fibrillation (AF) recurrence. Cardiome Pharma, Merck&#8217;s partner in the drug, <a href=\"http:\/\/www.cardiome.com\/investors\/news\/archives\/2012\/cardiome-provides-update-mercks-development-plans-vernakalant-oral\">said today<\/a> that the &#8220;decision was based on Merck&#8217;s assessment of the regulatory environment and projected development timeline.&#8221;<\/p>\n<p>Merck and Cardiome will continue their partnership with the intravenous formulation of vernakalant, Brinavess, which is approved in 37 countries outside the U.S. for the rapid conversion of recent-onset AF.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Merck has discontinued its development of oral vernakalant for the long-term prevention of atrial fibrillation (AF) recurrence. Cardiome Pharma, Merck&#8217;s partner in the drug, said today that the &#8220;decision was based on Merck&#8217;s assessment of the regulatory environment and projected development timeline.&#8221; Merck and Cardiome will continue their partnership with the intravenous formulation of vernakalant, [&hellip;]<\/p>\n","protected":false},"author":196,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[341,494],"class_list":["post-27348","post","type-post","status-publish","format-standard","hentry","category-electrophysiology","tag-atrial-fibrillation","tag-vernakalant"],"_links":{"self":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/27348","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/users\/196"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/comments?post=27348"}],"version-history":[{"count":0,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/27348\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/media?parent=27348"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/categories?post=27348"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/tags?post=27348"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}